Clinical Trial Update: Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating edoxaban for prevention of catheter-related thrombosis in cancer patients; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thrombosis

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Thrombosis, Venous, Cancer | Phase 3 | Status: NOT_YET_RECRUITING